GHRL and cardiovascular disorder: A large, 19-year, population-based prospective follow-up study in 491 hypertensive and 513 control subjects (cardiovascular disease incidence was a parallel outcome of the study) found that baseline plasma ghrelin level had no association with cancer deaths or hospital events in either cohort (Laurila et al. 2014).